ArticleCancer immunology, immunotherapy : CII2022
ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
Houshi Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it